26. CANNABIS GROUP

Cannabis, derived from Cannabis sativa and Cannabis indica, is one of the most widely used psychoactive substances. Its active components, cannabinoids—especially delta-9-tetrahydrocannabinol (THC)—produce euphoria, altered perception, and relaxation. Although cannabis toxicity is generally not fatal, acute and chronic use can lead to clinically significant physical and psychological effects.

Active Components

  • THC (Delta-9-tetrahydrocannabinol): main psychoactive agent
  • CBD (Cannabidiol): non-intoxicating, modulates THC effects
  • Other minor cannabinoids and terpenes

Mechanism of Action

Cannabinoids act on:

  • CB1 receptors (central nervous system)
  • CB2 receptors (immune system)

Activation of these receptors affects memory, motor coordination, appetite, perception, and mood.

Clinical Effects

Psychological Effects

  • Euphoria
  • Relaxation
  • Altered perception of time
  • Impaired attention and cognition
  • Anxiety or panic attacks

Physical Effects

  • Tachycardia
  • Conjunctival injection (red eyes)
  • Increased appetite
  • Dry mouth
  • Ataxia

Acute Toxicity

More common with high-potency THC products and edibles.

Symptoms

  • Severe anxiety or panic
  • Paranoia
  • Nausea and vomiting
  • Hallucinations (rare, high doses)
  • Tachycardia and hypertension
  • Drowsiness

Chronic Use Effects

  • Cannabis use disorder (dependence)
  • Memory impairment
  • Reduced motivation (“amotivational syndrome”)
  • Bronchitis in chronic smokers
  • Possible association with psychosis in vulnerable individuals

Complications

  • Accidents due to impaired motor skills
  • Severe vomiting: cannabinoid hyperemesis syndrome (CHS)
  • Cardiovascular events (rare but reported)

Diagnosis

  • Clinical history and symptoms
  • Urine drug screen (detects THC metabolites)

Management

1. Supportive Care

  • Reassurance in a quiet environment
  • Hydration
  • Observation until symptoms resolve

2. Sedation

  • Benzodiazepines for severe anxiety or agitation

3. Cannabinoid Hyperemesis Syndrome (CHS)

  • Hot showers may give temporary relief
  • IV fluids and antiemetics
  • Topical capsaicin therapy
  • Definitive treatment: cessation of cannabis use

4. Psychiatric Management

  • Support for substance dependence
  • Counseling for cannabis-related anxiety or psychotic features

Prevention & Harm Reduction

  • Avoid driving after cannabis use
  • Educate about potency differences (smoking vs. edibles)
  • Discourage use in adolescents and individuals with mental illness

Detailed Notes:

For PDF style full-color notes, open the complete study material below:

PATH: PHARMD/ PHARMD NOTES/ PHARMD FOURTH YEAR NOTES/ CLINICAL TOXICOLOGY/ CANNABIS GROUP.

Share your love